Incidence and Severity of Acute Cellular Rejection in Recipients Undergoing Adult Living Donor or Deceased Donor Liver Transplantation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Living donor liver transplantation (LDLT) may have better immunological outcomes compared to deceased donor liver transplantation (DDLT). The aim of this study was to analyze the incidence of acute cellular rejection (ACR) after LDLT and DDLT. Data from the adult-to-adult living donor liver transplantation (A2ALL) retrospective cohort study on 593 liver transplants done between May 1998 and March 2004 were studied (380 LDLT; 213 DDLT). Median LDLT and DDLT follow-up was 778 and 713 days, respectively. Rates of clinically treated and biopsy-proven ACR were compared. There were 174 (46%) LDLT and 80 (38%) DDLT recipients with >/=1 clinically treated episodes of ACR, whereas 103 (27%) LDLT and 58 (27%) DDLT recipients had >/=1 biopsy-proven ACR episode. A higher proportion of LDLT recipients had clinically treated ACR (p = 0.052), but this difference was largely attributable to one center. There were similar proportions of biopsy-proven rejection (p = 0.97) and graft loss due to rejection (p = 0.16). Longer cold ischemia time was associated with a higher rate of ACR in both groups despite much shorter median cold ischemia time in LDLT. These data do not show an immunological advantage for LDLT, and therefore do not support the application of unique posttransplant immunosuppression protocols for LDLT recipients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liver regeneration: from myth to mechanism
Taub, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1489 · Cited by 1,567 · cited 1×
“It has been well established that liver regeneration starts within minutes after partial hepatectomy and is associated with upregulation of cell cycle genes (21,22).”
BackgroundOlthoff, K. M., Merion, R. M., Ghobrial, R. M., Abecassis, M. M., Fair, J. H., Fisher, R. A., Freise, C. E., Kam, I., Pruett, T. L., Everhart, J. E., et al. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000179646.37145.ef · Cited by 352 · cited 1×
“In addition, the living donor procedure is well coordinated with the recipient operation, resulting in short cold ischemia time (16).”
BackgroundSelf-citationMajor effects of delayed graft function and cold ischaemia time on renal allograft survival
Quiroga, I., McShane, P., Koo, D. D. H., Gray, D., Friend, P. J., Fuggle, S., & Darby, C. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl042 · Cited by 331 · cited 1×
“Lessons learned in the deceased donor kidney transplant setting demonstrate that donor-related injury and prolonged cold ischemia time are associated with a higher rate of delayed graft function, and a subsequent increase in the frequency of ACR (19).”
BackgroundHLA compatibility and organ transplant survival. Collaborative Transplant Study.
Opelz, G., Wujciak, T., Döhler, B., Scherer, S., & Mytilineos, J. (1999) · PubMed · Cited by 308
Weiss, S., Kotsch, K., Francuski, M., Reutzel-Selke, A., Mantouvalou, L., Klemz, R., Kuecuek, O., Jonas, S., Wesslau, C., Ulrich, F., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01799.x · Cited by 237 · cited 1×
“Preliminary genomic studies on liver biopsies taken from brain dead and living donor liver donors demonstrate differences in regulation of proinflammatory response genes, which may reflect the differential degree of liver injury or relate to the duration of cold ischemia (17,18).”
BackgroundAdult Living Donor Versus Deceased Donor Liver Transplantation: A 6-Year Single Center Experience
Maluf, D. G., Stravitz, R. T., Cotterell, A. H., Posner, M. P., Nakatsuka, M., Sterling, R. K., Luketic, V. A., Shiffman, M. L., Ham, J. M., Marcos, A., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00654.x · Cited by 158 · cited 1×
“Other reports indicated a lower rate of rejection in a small number of LDLT recipients after relatively short-term follow-up (9,10).”
BackgroundSelf-citationvan der Hoeven, J. A. B., Molema, G., Horst, G. J. T., Freund, R. L., Wiersema, J., Schilfgaarde, R. V., Leuvenink, H. G. D., & Ploeg, R. J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00272.x · Cited by 148
Medical management to optimize donor organ potential: review of the literature
Kutsogiannis, D. J., Pagliarello, G., Doig, C. J., Ross, H. J., & Shemie, S. D. (2006) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03022800 · Cited by 120 · cited 1×
“This is very different than the brain dead donor that has experienced massive physiological and hormonal shifts, all of which may be harmful to the liver (15).”
BackgroundNavarro, V. J., Herrine, S. K., Katopes, C., Colombe, B., & Spain, V. C. (2006) · Liver Transplantation · doi:10.1002/lt.20680 · Cited by 96 · cited 1×
“The potential beneficial effect of more similar HLA identity in the living donor setting has not been proven for adult or pediatric patients receiving partial liver allografts from blood relatives (23,24).”
BackgroundSiddiqi, N., McBride, M., & Hariharan, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00589.x · Cited by 94
Time-Dependent Changes in Donor Brain Death Related Processes
Schuurs, T. A., Morariu, A. M., Ottens, P. J., Hart, N. A. ‘., Popma, S. H., Leuvenink, H. G. D., & Ploeg, R. J. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01547.x · Cited by 86
Debonera, F., Krasinkas, A. M., Gelman, A. E., Aldeguer, X., Que, X., Shaked, A. A., & Olthoff, K. M. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.036 · Cited by 48
Self-citationGene Expression Profiling of Acute Liver Stress During Living Donor Liver Transplantation
Borozan, I., Chen, L., Sun, J., Tannis, L.-L., Guindi, M. M., Rotstein, O. D., Heathcote, J., Edwards, A. M., Grant, D. R., & McGilvray, I. D. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01254.x · Cited by 39 · cited 1×
“Recent genomic analysis of deceased donor and living donor liver biopsy done within one hour after reperfusion demonstrated additional differential regulation of proinflammatory and immune response gene expression (6,18).”
BackgroundDebonera, F., Wang, G., Xie, J., Que, X., Gelman, A. E., LeClair, C., Xin, D., Shaked, A. A., & Olthoff, K. M. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00626.x · Cited by 27
Self-citation
Cited by
Martin, P., DiMartini, A., Feng, S., Brown, R., & Fallon, M. (2014) · Hepatology · doi:10.1002/hep.26972 · Cited by 1,045
“The role of locoregional therapies to control tumor growth in waitlisted candidates within the Milan criteria is an area of active investigation and a decision to perform tumor ablation can reflect a number of factors, including the candidate’s projected waiting time for transplant and ability to tolerate an intervent…”
BackgroundAcute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients
Levitsky, J., Goldberg, D., Smith, A. R., Mansfield, S. A., Gillespie, B. W., Merion, R. M., Lok, A. S. F., Levy, G., Kulik, L., Abecassis, M., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.07.035 · Cited by 236
“22 Earlier A2ALL data did not demonstrate differences in rejection risks based on donor type (live versus deceased).(7) However, the data focused on a smaller cohort and did not evaluate biological relatedness.”
Self-citationAcute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know
Choudhary, N. S., Saigal, S., Bansal, R. K., Saraf, N., Gautam, D., & Soin, A. S. (2017) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2017.10.003 · Cited by 181
From immunosuppression to tolerance
Adams, D. H., Sanchez-Fueyo, A., & Samuel, D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.042 · Cited by 181
“The incidence of clinically significant rejection is 10–40% in most series usually within the first month after transplantation [43] when liver injury results in elevated levels of bilirubin, transaminases and alkaline phosphatase [44].”
BackgroundRecurrence and rejection in liver transplantation for primary sclerosing cholangitis
Fosby, B. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i1.1 · Cited by 175
Metadata
- Authors
- Shaked, A., Ghobrial, R. M., Merion, R. M., Shearon, T. H., Emond, J. C., Fair, J. H., Fisher, R. A., Kulik, L. M., Pruett, T. L., & Terrault, N. A.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 9
- Issue
- 2
- Pages
- 301-308
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2074863174
- Cited by
- 162
- References
- 14
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.